{"id":4398,"date":"2022-08-29T14:40:04","date_gmt":"2022-08-29T09:10:04","guid":{"rendered":"http:\/\/finservwealth.com\/alembic-pharma-gets-usfda-nod-for-blood-pressure-drug\/"},"modified":"2022-08-29T14:40:04","modified_gmt":"2022-08-29T09:10:04","slug":"alembic-pharma-gets-usfda-nod-for-blood-pressure-drug","status":"publish","type":"post","link":"https:\/\/finservwealth.com\/hi\/alembic-pharma-gets-usfda-nod-for-blood-pressure-drug\/","title":{"rendered":"Alembic Pharma gets USFDA nod for blood pressure drug"},"content":{"rendered":"<p> The company has received final approval from the US Food and Drug Administration (USFDA) to market the product in the US in strengths of 25 mg and 50 mg, the drug maker said in a statement.<\/p><div id=\"finse-3725509844\" class=\"finse-content finse-entity-placement\"><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-9118214110898834\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block;\" data-ad-client=\"ca-pub-9118214110898834\" \ndata-ad-slot=\"\" \ndata-ad-format=\"auto\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/business\/alembic-pharma-gets-usfda-nod-for-blood-pressure-drug_16606551.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>The company has received final approval from the US Food and Drug Administration (USFDA) to market the product in the US in strengths of 25 mg and 50 mg, the drug maker said in a statement. Read More<\/p>","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[70],"tags":[],"class_list":["post-4398","post","type-post","status-publish","format-standard","hentry","category-latest-news"],"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/4398","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/comments?post=4398"}],"version-history":[{"count":0,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/4398\/revisions"}],"wp:attachment":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/media?parent=4398"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/categories?post=4398"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/tags?post=4398"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}